The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating KRAS: A 30-year Overnight Sensation.” The plenary session was chaired by Dafna Bar-Sagi, PhD, FAACR,...
Treatment vaccines are on the horizon, and immunotherapy drugs are effective in treating multiple myeloma.
The American Association for Cancer Research (AACR) is proud to offer Global Scholar-in-Training Awards (GSITA) to support the career development of meritorious early-career scientists from countries building cancer research capacities. This month, the GSITA...
Attentive care can manage conditions that cause patients to seek emergency care, but patients with concerning symptoms should still go to the hospital or urgent care center.
New therapy approved for locally advanced or metastatic bladder cancer, and court ruling could lead to cost hikes for certain cancer screenings.
The researchers are interested in understanding why some lesions turn into pancreatic cancer to better identify those with a high risk of the disease. A surprisingly large number of healthy people may be walking...
A targeted therapy is now available for more patients with advanced bladder cancers The U.S. Food and Drug Administration (FDA) has granted accelerated approval to enfortumab vedotin-ejfv (Padcev) in combination with pembrolizumab (Keytruda) for...
Cancer deaths linked to cigarette smoking account for millions of years in lost lives and billions of dollars in economic burden.
Researchers are striving to understand why men are more likely than women to get and die from many types of cancer.
While colorectal cancer incidence has gone down among older people, incidence rates have steadily increased for people under age 50. Younger people are more likely to be diagnosed at a later stage and have unique challenges that come with facing cancer in their prime.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More